With so many eye treatments on the market, whether looking at the retail counter, talking to your dermatologist or plastic surgeon, the issues most people want addressed where their eyes are concerned are to correct their dark circles, eye-area lines, wrinkles, dryness and inflammation.
Curtis A. Cluff Chief Executive Officer of Envy Medical, Inc commented that “Physicians and their patients have been telling us that they don’t have good options for treating dark under-eye circles. We realized that there was no single product that comprehensively addressed the issues in a safe and effective manner”. This led Lumixyl to work on Lumixyl Revitaleyes and tackle a combination of issues that addressed the changing area around the eyes.
What makes Lumixyl® Revitaleyes different? it is the first eye cream formulated with decapeptide-12 as part of a comprehensive treatment to correct dark circles, eye-area lines and wrinkles, dryness and inflammation, when researching other eye treatments Envy Medical only found one or two concerns are usually addressed in the treatment.
The ability of decapeptide-12 to reduce hyper pigmentation in skin can be reviewed in a few studies that have been published in leading journals including those in the Journal of Investigative Dermatology August 2009.
The combination of Chrysin, N-Hydroxysuccinimide, and EDTA to chelate iron deposits in skin in such a way that it can then be removed by the skins own natural processes. This can also be reviewed in an example of a study showing the efficacy of these ingredients is found Scientific Investigation and Clinical Summary: Age Intervention® Dark Circle Eye Defense where 80% to 100% of the 42 patients in two separate study sites showed significant improvement in dark eye circles caused by hemosiderin (an iron-storage complex found in blood cells).
So the advantage for Lumixyl® Revitaleyes is that it combines both the effective, proven treatment of darkening around the eye caused by hyper pigmentation with the darkening caused by the leaky blood vessels that deposit hemosiderin. Presently no other product has this combination for effective treatment, additionally anti-inflammatory agents to reduce puffiness, and hyaluronic acid to increase moisture content and reduce wrinkles – which will give immediate visual benefits while the other ingredients do the heavy work over 6 to 8 weeks.
While speaking with Curtis Cluff CEO Envy Medical, on the topic of blepharoplasty patients and their issues of darkening around the eyes after surgery, he commented that while no studies have been conducted poor circulation could indicate other problems not related to what is going on within the skin at the completion of surgery.
Envy Medical believes that Lumixyl® Revitaleyes will become very established as a post blepharoplasty treatment in addressing both the hemoglobin/hemosderin deposits that occur in greater visible quantities post procedure, as well as the Post Inflammatory Hyper pigmentation that occurs for many skin types after such a procedure. Lumixyl® Revitaleyes can be found on line in New York at Dr. Zdinak, Precision Aesthetics, 10 West 74th Street, New York NY 10023.
Comments